April 26, 2023 | 9:00am PT / 12:00pm ET | Presented by Oxford GlobalREGISTER NOW
Advances in mass spectrometry resolution and sensitivity have enabled increasingly comprehensive views into the multitude of small molecule metabolites circulating in humans. These metabolites read out diverse host and environmental exposures that influence human health and may serve as critical biomarkers for driving early disease diagnostics, precision medicine approaches, and clinical trial optimization.
In this webinar, we will share how Sapient has established discovery-as-a-service approaches that utilize next-generation, high throughput mass spectrometry, advanced data analysis, and population-scale data assets across >100,000 individuals to enable robust discovery of biomarkers that can be used to align patients, disease biology, and therapeutic interventions for clinical trials.
You will learn about:
- The role of small molecule biomarkers in providing insight into human disease biology and drug response
- Technologies enabling rapid identification of small molecule biomarkers of biological processes, disease progression, and drug response, including for clinical trial optimization
- Real-world examples of how Sapient’s small molecule biomarker discovery approaches have been used to advance clinical trials
Click here to register now!
High-Throughput Biomarker Discovery for Clinical Trial Optimization
April 26, 2023 | 9:00am PT / 12:00pm ET | Presented by Oxford Global REGISTER NOW Advances in mass spectrometry resolution and sensitivity have enabled increasingly comprehensive views into the multitude of small molecule metabolites circulating in… Read More
The Clinical Trial Conundrum: Identifying Responders vs. Non-Responders
Now On Demand | Hosted by AAPS Will a patient respond or not respond to the given therapy? That is the fundamental question for any clinical trial – and not an easy answer to predict. Patients are unique; diseases are dynamic and represent heterogenous biology, collectively… Read More
Fierce Webinar: Population-Scale Circulating Biomarker Discovery to Accelerate Drug Development
Now On Demand | Hosted by Fierce Pharma WATCH NOW In this session, Sapient discusses application of its next-generation mass spectrometry approaches for large-scale biomarker discovery across diverse human diseases, enabling measure of tens of thousands of small… Read More
What’s Next in Precision Medicine? Small Molecule Biomarkers to Personalize Disease Prediction, Diagnostics and Therapies
Now On Demand | Hosted by AAPS WATCH NOW While next-generation sequencing has been instrumental in advancing genomics-based precision medicine, the full potential of personalized therapy has yet to be realized at scale. DNA biomarkers help identify genetic… Read More
Mapping the Missing Link: Bridging the Gap Between Human Genetics and Disease Biology Through Small Molecule Biomarker Discovery
Now On Demand | Hosted by AAPS WATCH NOW Genome-wide association studies (GWAS) have been transformative in elucidating the genetic landscape of human disease, defining hundreds of common and rare genetic variants that contribute to the development… Read More
Identifying Non-Invasive Biomarkers of Target Engagement
Now On Demand | Hosted by AAPS WATCH NOW A key aspect of the drug discovery pipeline is evaluation of in vivo target engagement and subsequent biological response. While measures of target engagement are often optimized in cellular… Read More
Smaller, Faster & More Effective: Clinical Trial Enrichment Using Circulating Biomarkers
Now On Demand | Hosted by AAPS WATCH NOW Diseases are singularly defined but often represent varied groupings of contributing factors and pathways that ultimately produce a shared pathology. Heterogeneous molecular pathogenesis creates heterogeneity in treatment responsiveness, which… Read More
Large Scale Biomarker Discovery: Next-Gen Mass Spectrometry Profiling to Accelerate Drug Development
Now On Demand | Hosted by AAPS WATCH NOW Circulating biomarker discovery is a critical component of the drug discovery process, identifying markers that improve our understanding of complex disease processes and enable personalization of therapy, evaluation of… Read More